PMID: 2504359Jul 15, 1989Paper

Prospective randomised controlled trial of methods of call and recall for cervical cytology screening

BMJ : British Medical Journal
M PierceJ King

Abstract

To discover whether systematic methods of call and recall are more effective than a non-systematic method and to see which of the two systematic methods was more effective. Prospective randomised controlled trial over a year. One group general practice. 416 Women over 35 eligible for a smear test who had never had a cervical smear test or in whom a smear test was overdue (previous test more than five years before). One group received written invitations to have a smear taken. The second group had their notes tagged so that the doctor would remind them (when they attended for another reason) to have a smear test. No special intervention was made in the third group. Performance of a cervical smear test during the year of the study. 32% (45/140) of the screened group, 27% (39/142) of the tagged group, and 15% (20/134) of the control group had a smear test during the year. The percentage of women having a smear test in the screened group was not significantly different from that in the tagged group, but the percentages in the two groups were significantly different from that in the control group. Whether a woman had had a previous smear test significantly affected the uptake of the invitation to have a smear test independently of t...Continue Reading

References

Aug 23, 1975·Lancet·D L Sackett, W W Holland
Feb 1, 1986·Scandinavian Journal of Primary Health Care·F Olesen
May 1, 1987·Archives of Ophthalmology·A Kurosawa, S Sawaguchi
Jul 1, 1985·British Heart Journal·M F Oliver
Aug 1, 1967·Journal of Chronic Diseases·D Schwartz, J Lellouch
Dec 1, 1984·Journal of Epidemiology and Community Health·J M Chamberlain
Feb 12, 1983·British Medical Journal·A McPherson
Jan 7, 1984·British Medical Journal·R C LallemandV Box
Jun 12, 1982·British Medical Journal·N S GalbraithC Clifford

❮ Previous
Next ❯

Citations

Sep 7, 1991·Lancet·D J ChadwickJ C Gingell
May 1, 1995·European Journal of Cancer. Part B, Oral Oncology·J A JullienP M Speight
Oct 4, 1997·Health Policy·B A MarkhamC E Evans
May 29, 2002·Archives of Medical Research·Gabriela Torres-MejíaLeobardo Gil-Abadíe
Jun 1, 1996·Australian and New Zealand Journal of Public Health·J E Byles, R W Sanson-Fisher
Jun 1, 1996·Australian and New Zealand Journal of Public Health·J C HyndmanH Le Sueur
Aug 26, 1989·BMJ : British Medical Journal·N Masters, H Elmes
May 19, 1990·BMJ : British Medical Journal·G Fowler, D Mant
Jan 25, 1992·BMJ : British Medical Journal·A WilsonJ Cooney
Feb 22, 1992·BMJ : British Medical Journal·F D HobbsR Holder
Jul 23, 1994·BMJ : British Medical Journal·J Austoker
Dec 14, 2011·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Mary PierceStephanie Baldeweg
Mar 1, 2008·Journal of the American Medical Informatics Association : JAMIA·Judith W DexheimerDominik Aronsky
Sep 15, 2001·Journal of General Internal Medicine·D S TsengK M Hla
Jan 21, 2006·Journal of General Internal Medicine·Judith M E WalshEliseo J Pérez-Stable
Oct 16, 2012·Preventive Medicine·E FerroniUNKNOWN Methods to increase participation Working Group
Jul 17, 2008·American Journal of Preventive Medicine·Roy C BaronUNKNOWN Task Force on Community Preventive Services
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A F MarkhamD M Meredith
Dec 3, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Rima Marhayu Abdul RashidMaznah Dahlui
Aug 6, 2010·Social Science & Medicine·Richard A Dunn, Andrew K G Tan
Jan 1, 1996·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·P CurtisS Hendrix
Aug 24, 2000·International Journal of Cancer. Journal International Du Cancer·G Torres-MejíaE Buiatti
Jan 1, 1993·Cytopathology : Official Journal of the British Society for Clinical Cytology·A R Chang
Jan 1, 1990·Cytopathology : Official Journal of the British Society for Clinical Cytology·A J RobertsonR Halkerston
Sep 9, 1989·BMJ : British Medical Journal
May 13, 2011·The Cochrane Database of Systematic Reviews·Thomas EverettRuth G Jepson
Apr 1, 1995·Australian Journal of Public Health·D A PritchardJ Hyndman
Jul 1, 1994·Journal of Medical Screening·J E BylesS Halpin
Mar 1, 1991·Australian Journal of Public Health·D TurnbullP Adelson
Jan 1, 1995·Journal of Medical Screening·J BowmanS Redman
Jun 1, 1994·Australian Journal of Public Health·A E MillsD A Turnbull
Sep 4, 1995·The Medical Journal of Australia·J J BeilbyA M Maddock
May 4, 2021·The Lancet. Public Health·Alejandra CastanonJames F O'Mahony
Oct 18, 1993·The Medical Journal of Australia·J C Litt, P B Lake

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.